Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00136604
Status:
COMPLETED
Last Update Posted:
2020-02-20
First Post:
2005-08-26
Brief Title:
Response to GSK Biologicals Tritanrix-HepBHib-MenAC Vacc 4th Dose at 15-24m Mencevax ACWY at 24-30m
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline
Organization Data
Organization:
GlaxoSmithKline
Class:
INDUSTRY
Study ID:
104727 Booster - 15-24 mths
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
GlaxoSmithKline
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None